Zydus seeks DCGI approval for clinical trial of monoclonal antibodies cocktail
NEW DELHI: SARS-CoV-2 spike protein targeted, neutralizing monoclonal antibody based treatments have received emergency use authorization in mild COVID cases...
NEW DELHI: SARS-CoV-2 spike protein targeted, neutralizing monoclonal antibody based treatments have received emergency use authorization in mild COVID cases...